MAIA Biotechnology, Inc.
MAIA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001878313
In the last 90 days, MAIA Biotechnology, Inc. insiders filed 5 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $19.4M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding MAIA Biotechnology, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 12 | 14 | +2 |
| Shares | 321.9K | 318.3K | −3.63K (−1.1%) |
| Value | $709.1K | $699.6K | −$9.45K (−1.3%) |
New holders (5)
Institutions that held MAIA Biotechnology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 17,550 | $38.0K | 0.02% |
| Morgan Stanley | 5,095 | $11.2K | 0.00% |
| UBS Group AG | 133 | $293 | 0.00% |
| Sunbelt Securities, Inc. | 50 | $110 | 0.00% |
| JPMorgan Chase & Co | 11 | $24 | 0.00% |
Sold out (3)
Institutions that held MAIA Biotechnology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Lynwood Capital Management Inc. | 35,000 | $77.0K |
| Citadel Advisors LLC | 23,387 | $51.5K |
| Renaissance Technologies LLC | 10,800 | $24.0K |